Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
allogeneic hematopoietic stem cells (Hemacord) (1 trial)
autologous hematopoietic stem cells (1 trial)
bone autograft (1 trial)
busulfan (Myleran) (1 trial)
cytarabine (cytosar-u) (1 trial)
hydroxyurea (hydrea) (1 trial)
idarubicin (idamycin) (1 trial)
interferon alpha-2b (Intron-A) (1 trial)
Leukemia (Phase 3)
Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 3)
Leukemia, Myeloid (Phase 3)
Trials (1 total)
Trial APIs (8 total)